Short-term gentamicin therapy and risk of renal toxicity in patients with bacteraemia

Marianne H Spanggaard1, Bo L Hønge, Henrik C Schønheyder

  • 1Department of Infectious Diseases, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark.

Insights

Short-term gentamicin (≤ 5 days) administration did not increase renal impairment risk in patients with community-acquired bacteremia. Renal safety was similar between gentamicin-exposed and non-exposed groups, indicating no significant difference in kidney function.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Pharmacology

Background:

  • Gentamicin's renal safety is a concern, particularly with once-daily dosing.
  • Previous studies have raised questions about potential kidney damage from gentamicin.

Purpose of the Study:

  • To evaluate the renal safety of short-term, once-daily gentamicin in adult patients with community-acquired bacteremia.
  • To compare the incidence of renal impairment between gentamicin-exposed and non-exposed patient groups.

Main Methods:

  • Retrospective cohort study of adult patients with community-acquired bacteremia.
  • Inclusion criteria: no chronic renal disease or malignancy, gentamicin treatment ≤ 5 days (n=165) or no aminoglycosides (n=150).
  • Primary endpoint: plasma creatinine elevation > 40 μmol/l from baseline; secondary endpoint: 30-day mortality.

Main Results:

  • Elevated creatinine occurred in 7.9% of gentamicin-exposed patients versus 8.7% of non-exposed patients (p=0.80).
  • Follow-up creatinine normalized in 67% of exposed and 78% of non-exposed patients with elevated creatinine (p=0.66).
  • 30-day mortality was 7.9% for exposed and 7.3% for non-exposed patients (p=0.86).

Conclusions:

  • Short-term (≤ 5 days) gentamicin administration is not associated with increased renal impairment in bacteremic patients.
  • Renal impairment in this context appears independent of gentamicin use.
  • Gentamicin can be considered safe for short-term use in this patient population regarding renal function.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...